gdc-0973 and Polymyalgia-Rheumatica

gdc-0973 has been researched along with Polymyalgia-Rheumatica* in 2 studies

2 other study(ies) available for gdc-0973 and Polymyalgia-Rheumatica

Article	Year
Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor. Annals of the rheumatic diseases, 2019, Volume: 78, Issue:7 Topics: Azetidines; Giant Cell Arteritis; Humans; Neoplasms; Piperidines; Polymyalgia Rheumatica; Prospective Studies	2019
Response to: 'Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor' by Chan and Bass. Annals of the rheumatic diseases, 2019, Volume: 78, Issue:7 Topics: Azetidines; Giant Cell Arteritis; Humans; Neoplasms; Piperidines; Polymyalgia Rheumatica; Prospective Studies	2019